Literature DB >> 31355792

In Vivo Two-Color 2-Photon Imaging of Genetically-Tagged Reporter Cells in the Skin.

Thomas A Szabo-Pardi1, Nilesh M Agalave1, Ashley T Andrew1, Michael D Burton2.   

Abstract

Fibroblasts are mesenchymal cells that change their morphology upon activation, ultimately influencing the microenvironment of the tissue they are located in. Although traditional imaging techniques are useful in identifying protein interactions and morphology in fixed tissue, they are not able to give insight as to how quickly cells are able to bind and uptake proteins, and once activated how their morphology changes in vivo. In the present study, we ask 2 major questions: 1) what is the time-course of fibroblast activation via toll-like receptor-4 (TLR4) and lipopolysaccharide (LPS) interaction and 2) how do these cells behave once activated? Using 2-photon imaging, we have developed a novel technique to assess the ability of LPS-FITC to bind to its cognate receptor, TLR4, expressed on peripheral fibroblasts in the genetic reporter mouse line; FSP1cre; tdTomatolox-stop-lox in vivo. This unique approach allows researchers to create in-depth, time-lapse videos and/or pictures of proteins interacting with live cells that allows one to have an increased level of granularity in understanding how proteins can alter cellular behavior.

Entities:  

Mesh:

Year:  2019        PMID: 31355792     DOI: 10.3791/59647

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  2 in total

1.  Utilizing multiphoton imaging and integrative clearing to reveal sex differences in neuroimmune interactions after nerve injury.

Authors:  Zachary W Castillo; Michael D Burton
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

2.  Use of Integrated Optical Clearing and 2-Photon Imaging to Investigate Sex Differences in Neuroimmune Interactions After Peripheral Nerve Injury.

Authors:  Thomas A Szabo-Pardi; Umar M Syed; Zachary W Castillo; Michael D Burton
Journal:  Front Cell Dev Biol       Date:  2021-02-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.